DelveInsight
0 FOLLOWERS
We are a business consulting firm with deep industry expertise in life science vertical with core focus on pharma and biotech industries. We consistently help our clients in taking sound decisions facilitating better business performances and achieving incredible growth.
Since its inception, DelveInsight has played a pioneering role in providing state of the art services to its clients and..
DelveInsight
2h ago
Brilaroxazine, developed by Reviva Therapeutics, exhibits potent affinity and selectivity against key serotonin and dopamine ..read more
DelveInsight
2h ago
Despite the urgent need for novel treatments, drug development for cognitive impairment associated with schizophrenia ..read more
DelveInsight
2h ago
LYN-005’s once-weekly dosing regimen reduces the pill burden for individuals with schizophrenia and schizoaffective disorders ..read more
DelveInsight
2h ago
In the landscape of schizophrenia treatment, there are significant gaps that affect patients' lives profoundly ..read more
DelveInsight
2h ago
KarXT, likely to receive the nod from the US FDA by late 2024, will significantly ..read more
DelveInsight
2h ago
Unlike traditional antipsychotic medications that block dopamine receptors, CVL-231 selectively modulates the M4 receptor in ..read more
DelveInsight
1w ago
Epidermolysis bullosa is a genetic skin condition marked by severe skin sensitivity and the formation ..read more
DelveInsight
1w ago
Regeneron Updates Progress on Biologics License Application for Odronextamab Regeneron Pharmaceuticals, Inc. has announced that ..read more
DelveInsight
1w ago
TELA Bio Launched FDA-approved Hernia Mesh Fixation Devices On March 21, 2024, TELA Bio, Inc ..read more
DelveInsight
1w ago
In the realm of cancer treatment, the development of targeted therapies has been nothing short ..read more